This segment focuses on developing and commercializing diagnostic solutions for immediate use in veterinary clinics. Heska's POC diagnostics include chemistry analyzers (Element DC, RC series), hematology analyzers (Element HT5, scil Vet abc Plus), blood gas and electrolyte analyzers (Element POC), and immunodiagnostic analyzers (Element i). These technologies enable veterinarians to quickly assess a patient's health status, facilitating timely treatment decisions. R&D efforts are directed towards improving the accuracy, speed, and ease of use of these diagnostic tools. The segment addresses a wide range of clinical needs, from routine health screenings to critical care diagnostics, impacting patient outcomes by enabling faster and more informed veterinary interventions. Future opportunities include expanding the range of available tests and integrating advanced data analytics for enhanced diagnostic insights.

This segment encompasses a diverse portfolio of products and services beyond core diagnostics, including allergy products (ALLERCEPT panels, therapy shots/drops), heartworm preventatives (Tri-Heart Plus), digital radiography hardware, ultrasound systems, and telecytology services (HeskaView). Research and development in this area focus on expanding the range of allergy therapies, improving imaging technologies, and enhancing the capabilities of telecytology for remote diagnosis. These products and services address specific needs in veterinary medicine, such as allergy management, parasite prevention, and advanced imaging diagnostics. By offering a comprehensive suite of solutions, Heska aims to improve the quality of care and enhance the efficiency of veterinary practices. Future growth potential lies in developing innovative therapies, expanding the reach of telecytology services, and integrating these offerings with diagnostic data for a more holistic approach to patient care.